Valuation (28%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | N/A | 30.75 |
| PEG Ratio (TTM) | N/A | 5.05 |
| P/S Ratio (TTM) | N/A | 85.45 |
| P/B Ratio (TTM) | 0.55 | 75.17 |
| P/FCF Ratio (TTM) | 13.99 | 67.11 |
| Price to 5YR AVG Earnings Ratio | N/A | 26.08 |
| Price to 5YR AVG FCF Ratio | -107.59 | 49.89 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | N/A | 4.34% |
| ROE (TTM) | N/A | 8.95% |
| Net Profit Margin (TTM) | N/A | -12.17% |
| ROIC 5YR AVG | 6.91% | 17.02% |
Growth (92%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 51.10% | 52.40% | 38.46% |
| Revenue | 163.09% | 75.01% | 42.61% |
| Net Income | 50.59% | 76.62% | 52.14% |
| Cash Flow | 131.30% | -278.80% | 604.56% |
Health (28%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.23 | 5.96 |
| Quick Ratio (TTM) | 0.23 | 5.82 |
| D/E Ratio (TTM) | N/A | 0.74 |
| Interest Coverage (TTM) | N/A | 15.74 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 34.98 | 5.83 |
| LTL to 5YR AVG FCF | N/A | 2.35 |
| Shares Outstanding Growth 5YR AVG | 10.06% | 12.17% |